Common Contracts
2 similar Underwriting Agreement contracts by Anchiano Therapeutics Ltd., Cingulate Inc.
CINGULATE INC. [____] Shares Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 1st, 2021 • Cingulate Inc. • Pharmaceutical preparations • New York
ANCHIANO THERAPEUTICS LTD. 2,652,174 American Depositary Shares Representing 13,260,870 Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • February 14th, 2019 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations • New York
Anchiano Therapeutics Ltd., a company organized under the laws of the State of Israel (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters (the “Underwriters”) named on Schedule I to this Underwriting Agreement (the “Agreement”), for whom you are acting as Representative (the “Representative”), an aggregate of 2,652,174 American Depositary Shares (the “Firm Shares”), representing an aggregate of 13,260,870 ordinary shares, no par value per share, of the Company (the “Ordinary Shares”) (“ADSs” shall mean the American Depositary Shares of the Company, each ADS representing five (5) Ordinary Shares). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 397,826 ADSs (representing 1,989,130 Ordinary Shares, in the aggregat
